Endotoxin Release from Neisseria Meningitidis: Relationship between Key Bacterial Characteristics and Meningococcal Disease

11. References

• Hirsch A. Meningitis cerebrospinalis epidemica. In: Die Organkrankheiten vom historisch-geographischen Standpunkte und mit besonderer Berücksichtigung der Ätiologie. Verlag von Ferdinand Enke, Stuttgart, 379–414, 1886
   Google Scholar
• Netter A. The efficacy of anti-meningococcal serum in the present epidemic of cerebro-spinal meningitis. Br J Child Dis 12: 353–366, 1915
   Google Scholar
• Greenwood BM, Greenwood AM, Bradley AK, Williams K, Hassan-King M, Shenton FC, Wall RA, Hayes RJ. Factors influencing susceptibility to meningococcal disease during an epidemic in the Gambia, West-Africa. J Infection 14: 167–184, 1987
   PubMed Web of Science ®Google Scholar
• Communicable disease report. Abberant biochemical behaviour of meningococci. CDR Weekly Edition 87/07: 1, 1987
   Google Scholar
• Stephens DS, McGee ZA. Association of virulence of Neisseria meningitidis transparent colony type and low-molecular-weight outer membrane proteins. J Infect Dis 147: 282–292, 1983
   PubMedGoogle Scholar
• Olyhoek, T, Crowe B, Achtman M. Evidence for clonal structure in Neisseria meningitidis: Relevance to epidemiology. Antonie van Leeuwenhoek 52: 202–205, 1986
   Google Scholar
• Caugant DA, Bøvre K, Gaustad P, Bryn K, Holten E. Høiby EA, Frøholm LO. Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol 132: 641–652, 1986
   PubMedGoogle Scholar
• Kristiansen B-E, Sørensen B, Bjorvatn B. Falk E, Fosse E, Bryn K. Frøholm LO. Bøvre K. An outbreak of group B meningococcal disease: Tracing the causative strain of Neisseria meningitidis by DNA fingerprinting. J Clin Microbiol 23: 764–767, 1986
   PubMed Web of Science ®Google Scholar
• Mulks MH, Plaut AG, Feldman HA, Frangione B. IgA proteases of two distinct specificities are released by Neisseria meningitidis. J Exp Med 152: 1442–1447, 1980
   PubMed Web of Science ®Google Scholar
• Chen KCS, Buchanan TM. Hydrolases from Neisseria: Pathogenesis and diagnostic implications. In: Danielsson D, Normark S, eds. Genetics and immunbiology of pathogenic Neisseria. Proceedings of EMBO workshop, Hemavan, Sweden, 16–19 June, 229, 1980
   Google Scholar
• Jyssum K, Lie S. Genetic factors determining competence in transformation of Neisseria meningitidis. 1. A permanent loss of competence. Acta Pathol Microbiol Scand 63: 306–316, 1965
   PubMedGoogle Scholar
• Brener D, DeVoe IW, Holbein BE. Increased virulence of Neisseria meningitidis after in vitro iron limited growth at low pH. Infect Immun 33: 59–66, 1981
   PubMed Web of Science ®Google Scholar
• Simonson C, Brener D, DeVoe IW. Expression of a high-affinity mechanism for acquisition of transferrin iron by Neisseria meningitidis. Infect Immun 36: 107–113, 1982
   PubMed Web of Science ®Google Scholar
• Verschueren H, Dekegel M, Dekegel D, Gilquin C, De Mayer S. Plasmids in Neisseria meningitidis. Lancet 1: 851–852, 1982
   PubMedGoogle Scholar
• Facinelli B, Varaldo PE. Plasmid-mediated sulfonamide resistance in Neisseria meningitidis. Antimicrob Agents Chemother 31: 1642–1643, 1987
   PubMedGoogle Scholar
• Ashton FE, Ryan A, Diena B, Jennings HJ. A new serogroup (L) of Neisseria meningitidis. J Clin Microbiol 17: 722–727, 1983
   PubMedGoogle Scholar
• Berger U. New serogroups of Neisseria meningitidis isolated in the Federal Republic of Germany. Eur J Clin Microbiol 4: 351, 1985
   PubMedGoogle Scholar
• Craven DE, Shen KT, Frasch CE. Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes. Infect Immun 37: 132–137, 1982
   PubMedGoogle Scholar
• Masson LB, Holbein BE, Ashton FE. Virulence linked to polysaccharide production in serogroup B Neisseria meningitidis. FEMS Microbiol Lett 13: 187–190, 1982
   Google Scholar
• Masson L, Holbein BE. Influence of environmental conditions on serogroup B Neisseria meningitidis capsular polysaccharide levels. In: Schoolnik GK, eds. The pathogenic Neisseria. Proceedings of the 4th International Symposium, Asomilar, California, 21–25 October 1984. Washington DC: American Society for Microbiology, 571–578, 1985.
   Google Scholar
• Ross SC, Berberich HM, Densen P. Natural serum bactericidal activity against Neisseria meningitidis isolates from disseminated infections in normal and complement-deficient hosts. J Infect Dis 152: 1332–1335, 1985
   PubMedGoogle Scholar
• Salit IE, Tomalty L. Experimental meningococcal infection in mice: A model for mucosal invasion. Infect Immun 51: 648–652, 1986
   PubMedGoogle Scholar
• Stephens DS, Whitney AM, Melly MA, Hoffman LH, Farley MM, Frasch CE. Analysis of damage to human ciliated nasopharyngeal epithelium by Neisseria meningitidis. Infect Immun 51: 579–585, 1986
   PubMedGoogle Scholar
• Devine LF, Rhode SL III, Hagerman CR. Relationship of serogroups of Neisseria meningitidis. II. R variants of Neisseria meningitidis. Infect Immun 5: 48–54, 1972
   PubMedGoogle Scholar
• Bryn K, Frøholm LO, Holten E, Bøvre K. Gas-chromatographic screening of capsular polysaccharides of Neisseria meningitidis. NIPH Annals 6: 91–101, 1983
   PubMedGoogle Scholar
• Riou JY, Guibourdenche M, Popoff MY. A new taxon in the genus Neisseria. Ann Microbiol (Paris) 134: 257–267, 1983
   Google Scholar
• Frasch CE, Zollinger WD, Poolman JT. Proposed scheme for identification of serotypes of Neisseria meningitidis. In: Schoolnik GK, eds. The pathogenic Neisseria. Proceedings of the 4th International Symposium, Asomilar, California, 21–25 October 1984. Washington DC: American Society for Microbiology, 519–524, 1985.
   Google Scholar
• Frasch CE. Noncapsular surface antigens of Neisseria meningitidis. In: Weinstein L, Fields BN, eds. Seminars in Infectious Diseases. II. Stratton Intercont Med Book Corp, 304–337, 1979
   Google Scholar
• Poolman JT, Hopman CT, Zanen HC. Colony variants of Neisseria meningitidis strain 2996 (B:2b:P1.2): influence of class-5 outer membrane proteins and the lipopolysaccharides. J Med Microbiol 19: 203–209, 1985
   PubMed Web of Science ®Google Scholar
• Abdillahi H, Poolman JT, Hopman CTP, Zanen HC. Sero- and subtyping of non-2a, non-2b, and non-15 group B Neisseria meningitidis. Antonie van Leeuwenhoek 52: 242–244, 1986
   Google Scholar
• Fallon RJ. Meningococcal serotypes and serogroup B disease in North-West Europe. Lancet 2: 807, 1986
   PubMedGoogle Scholar
• Ashton FE, Ryan JA, Diena BB. Meningococcal serotypes in Canada, 1977–1984. Antonie van Leeuwenhoek 52: 245–246, 1986
   Google Scholar
• Fallon RJ. Meningococcal infections: First and second quarters, 1987 (Serotyping performed by H. Abdillahi). CDS 46: 5–9, 1987
   Google Scholar
• Mandrell RE, Zollinger WD. Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition. Infect Immun 16: 471–475, 1977
   PubMed Web of Science ®Google Scholar
• Zollinger WD, Mandrell RE. Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid phase radioimmunoassay. Infect Immun 18: 424–433, 1977
   PubMedGoogle Scholar
• Tsai C-M, Mocca LF, Frasch CE. Immunotype epitopes of Neisseria meningitidis lipooligosac-charide types 1 through 8. Infect Immun 55: 1652–1656, 1987
   PubMed Web of Science ®Google Scholar
• Poolman JT, Wientjes FB, Hopman CT, Zanen HC. Influence of the lengt of lipopolysaccharide molecules on the surface exposure of class 1 and 2 outer membrane proteins of Neisseria meningitidis 2996 (B:2b:P1.2). In: Schoolnik GK, eds. The pathogenic Neisseria. Proceedings of the 4th International Symposium, Asomilar, California, 21–25 October 1984. Washington DC: American Society for Microbiology, 562–570, 1985.
   Google Scholar
• Millar JW, Siess EE, Feldman HA, Silverman C, Frank P. In vivo and in vitro resistance to sulfadiazine in strains of Neissera meningitidis. J Am Med Ass 186: 139–141, 1963
   PubMed Web of Science ®Google Scholar
• Holten E, Vaage L, Neess C, Midtvedt T, Jyssum K. Sulphonamide-resistant meningococci after sulphonamide prophylaxis among naval recruits in Norway. Scand J Infect Dis 1: 185–189, 1969
   PubMedGoogle Scholar
• Feldman HA. Meningococcal disease 1965. JAMA 196: 105–107, 1966
   Google Scholar
• Murray EGD, Ayrton R. Observations on the growth of meningococci in vitro in relation to virulence. J Hyg Camb 23: 23–63, 1924
   PubMedGoogle Scholar
• Cohen SM. A study of the virulence of meningococcus strains and of the protective activity of antimeningococcus sera. J Immunol 30: 203–212, 1936
   Google Scholar
• Tikhomirov E. Meningococcal meningitis: Global situation and control measures. Wld Hlth Statist Quartan 40: 98–109, 1987
   PubMedGoogle Scholar
• Baroyan OV, Bolshakov KN, Genchikov LA. Periodicity of meningococcal meningitis. Zhurnal Mikrobiol 4: 68–73, 1974
   Google Scholar
• Glover JA. Observations of the meningococcus carrier rate, and their application to the prevention of cerebrospinal fever. Med Research Council Spec Report Series 50: 133–165, 1920
   Google Scholar
• Aycock WL, Mueller HJ. Meningococcus carrier rates and meningitis incidence. Bacteriol Rev 14: 115–160, 1950
   PubMedGoogle Scholar
• Lapeyssonie L. La meningite cerebro-spinal en Afrique. Bull WHO Suppl 28, 1963
   Google Scholar
• Greenwood BM, Blakebrough IS, Bradley AK, Wali S, Whittle HC. Meningococcal disease and season in Sub-Saharan Africa. Lancet 1: 1339–1342, 1984
   PubMed Web of Science ®Google Scholar
• Greenwood BM, Bradley AK, Cleland PG, Haggie MHK, Hassan-King M, McFarlane JT, Taqi A, Whittle HC. An epidemic of meningococcal infection in Zaria, Northern Nigeria. 1. General epidemiological features. Trans R Soc Trop Med Hyg 73: 557–562, 1979
   PubMed Web of Science ®Google Scholar
• Bøvre K, Gedde-Dahl TW. Epidemiological patterns of meningococcal disease in Norway 1975–1979. NIPH Ann 3: 9–22, 1980
   PubMedGoogle Scholar
• Fallon RJ, Brown WM, Lore W. Meningococcal infections in Scotland 1972–82. J Hyg Camb 93: 167–180, 1984
   PubMedGoogle Scholar
• de Marie S, Poolman JT, Hoeijmakers JH, Bol P, Spanjaard L, Zanen HC. Meningococcal disease in the Netherlands, 1959–1981: The occurrence of serogroups and serotypes 2a and 2b of Neisseria meningitidis. Br Soc Study Infect 12: 13–143, 1986
   Google Scholar
• Frøholm LO, Holten E, Høiby EA, Caugant DA, Zollinger WD. Monitoring of epidemic meningococcal strains from Norway. Fifth International Pathogenic Neisseria Conference 14–18 Sept, 1986, Noordwijkerhout, The Netherlands
   Google Scholar
• Aasen S, Lystad A, Hareide B. Meningokokksykdom, gruppe C. Utbrudd i Luster kommune, Sogn og Fjordane. MSIS, uke 17, 1988
   Google Scholar
• Holten E. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J Clin Microbiol 9: 186–188, 1979
   PubMed Web of Science ®Google Scholar
• Holten E, Frøholm LO, Gaustad P. Virulence markers in patient and carrier strains of Neisseria meningitidis. Scand J Infect Dis 16: 267–270, 1984
   PubMed Web of Science ®Google Scholar
• Frøholm LO, Holten E, Poolman JT, Zollinger WD. Typing of Norwegian meningococcal isolates and possible implications for serogroup B vaccination. In: Schoolnik GK. ed. The pathogenic Neisseria. Proceedings of the 4th International Symposium, Asomilar, California, 21–25 October 1984. Washington DC: American Society for Microbiology, 541–545, 1985.
   Google Scholar
• Poolman JT, Lind I, Jonsdottir K, Frøholm LO. Jones DM, Zanen HC. Meningococcal serotypes and serogroup B disease in North-West Europe. Lancet 2: 555–557, 1986
   PubMed Web of Science ®Google Scholar
• Severin WPJ. Over de epidemie van meningitis cerebrospinalis epidemica in Nederland in 1966. Thesis. 1968
   Google Scholar
• Salmi I. Pettay O, Simula I, Kallio A-K, Waltimo O. An epidemic due to sulphonamide-resistant group A meningococci in the Helsinki Area (Finland). Epidemiological and clinical observations. Scand J Infect Dis 8: 249–254, 1976
   PubMed Web of Science ®Google Scholar
• Bøvre K, Holten E, Vik-Mo H, Brøndbo A, Bratlid D, Bjark P, Moe PJ. Neisseria meningitidis infections in northern Norway: an epidemic in 1974–1975 due mainly to group B organisms. J Infect Dis 135: 669–672, 1977
   PubMed Web of Science ®Google Scholar
• Andersen BM. Disease and mortality caused by Neisseria meningitidis. The role of endotoxin liberation as a virulence factor. J Oslo City Hosp 33: 37–68, 1983
   PubMedGoogle Scholar
• Andersen BM. Mortality in meningococcal infections. Scand J Infect Dis 10: 277–282, 1978
   PubMed Web of Science ®Google Scholar
• Brøndbo A, Vik-Mo H, Moe PJ, Bøvre K. Meningokokkepidemien i Nord-Norge 1974–1975. Et klinisk materiale fra Regionsykehuset i Tromsø. Tidsskr Nor Lægeforen 97: 810–812, 1977
   PubMedGoogle Scholar
• Gundersen T, Ibsen T. Meningokokkinfeksjon. Sykdomsbilde, behandling og komplikasjoner. Tidsskr Nor Lægeforen 97: 1663–1667, 1977
   PubMedGoogle Scholar
• Bjark P. Meningococcal infections in a district hospital. Some clinical observations and therapeutic experiences during an epidemic in North Norway. NIPH Ann 3: 83–90, 1980
   PubMedGoogle Scholar
• Bergh K, Mürer FA. Meningokokkinfeksjoner. Et 6 års materiale fra Rana sykehus. Tidsskr Nor Lægeforen 102: 5–8, 1982
   PubMedGoogle Scholar
• Peltola H, Jonsdottir K, Lystad A, Sievers CJ, Kallings I. Meningococcal disease in Scandinavia. Br Med J 284: 1618–1621, 1982
   PubMed Web of Science ®Google Scholar
• Halstensen A, Pedersen SHJ, Haneberg B, Bjorvatn B, Solberg CO. Case fatality of meningococcal disease in Western Norway. Scand J Infect Dis 19: 35–43, 1987
   PubMed Web of Science ®Google Scholar
• Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 137: 112–121, 1978
   PubMed Web of Science ®Google Scholar
• Saez-Nieto JA, Dominguez JR, Monton JL, Cristobal P, Fenoll A, Vazquez J, Casal J, Taracena B. Carriage of Neisseria meningitidis and Neisseria lactamica in a school population during an epidemic period in Spain. J Hyg Camb 94: 297–288, 1985
   Google Scholar
• Cartwright KAV, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: Nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidem Inf 99: 591–601, 1987
   PubMed Web of Science ®Google Scholar
• Cann KJ, Rogers TR, Jones DM, Noah ND, Burns C. Neisseria meningitidis in a primary school. Arch Dis Child 62: 1113–1117, 1987
   PubMed Web of Science ®Google Scholar
• Frøholm LO, Berdal BP, Bøvre K, Gaustad P, Harboe A, Holten E, Høiby EA, Lystad A, Omland T, Frasch CE. Meningococcal group B vaccine trial in Norway 1981–1982. Preliminary report of results available November 1982. NIPH Ann 6: 133–138, 1983
   PubMedGoogle Scholar
• Foster MT, Sanders E, Ginter M. Epidemiology of sulfonamide-resistant meningococcal infections in a civilian population. Am J Epidemiol 93: 346–353, 1971
   PubMed Web of Science ®Google Scholar
• Holten E, Bratlid D, Bøvre K. Carriage of Neisseria meningitidis in a semi-isolated arctic community. Scand J Infect Dis 10: 36–40, 1978
   PubMed Web of Science ®Google Scholar
• Greenfield S, Sheehe PR, Feldman HA. Meningococcal carriage in a population of “normal” families. J Infect Dis 123: 67–73, 1971
   PubMed Web of Science ®Google Scholar
• Edwards EA, Devine LF, Sengbusch CH, Ward HW. Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence. Scand J Infect Dis 9: 105–110, 1977
   PubMed Web of Science ®Google Scholar
• Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129: 1327–1347, 1969
   PubMed Web of Science ®Google Scholar
• Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 129: 1327–1347, 1969
   PubMed Web of Science ®Google Scholar
• Lehman V, Solberg CO. Group B meningococcal opsonins in serum measured by polymorphonuclear leukocyte chemiluminescence. Acta Pathol Microbiol Scand (C) 88: 227–231, 1980
   Google Scholar
• Schur PH. Inherited complement component abnormalities. Ann Rev Med 37: 333–346, 1986
   PubMed Web of Science ®Google Scholar
• Powars DR, Rogers ZR, Patch MJ, McGhee WG, Francis RB. Purpura fulminans in meningococcemia: Association with acquired deficiencies of proteins C and S. N Engl J Med 317: 571–572, 1987
   PubMedGoogle Scholar
• Holmes FF, Weyandt T, Glazier J, Cuppage FE, Moral LA, Lindsey NJ. Fulminant meningococcemia after splenectomy. JAMA 246: 1119–1121, 1981
   Google Scholar
• Heier HE. Splenectomy and serious infections. Scand J Haematol 24: 5–12, 1980
   PubMedGoogle Scholar
• Ødegaard K, Gedde-Dahl TW. Frequency of simultaneous carriage of Neisseria gonorrhoeae and Neisseria meningitidis. Br J Ven Dis 55: 334–335, 1979
   PubMedGoogle Scholar
• Winstanley FP, Blackwell CC, Weir DM. Factors influencing host susceptibility to meningococcal disease. Biomed Pharmacotherapy 39: 167–170, 1985
   PubMedGoogle Scholar
• Filice GA, Hayes PS, Counts GW, Griffiss JM, Fraser DW. Risk of group A meningococcal disease: Bacterial interference and cross-reactive bacteria among mucosal flora. J Clin Microbiol 22: 152–156, 1985
   PubMedGoogle Scholar
• Niklasson P-M, Lundbergh P, Strandell T. Prognostic factors in meningococcal disease. Scand J Infect Dis 3: 17–25, 1971
   PubMedGoogle Scholar
• Olcén P, Barr J, Kjellander J. Meningitis and bacteremia due to Neisseria meningitidis: Clinical and laboratory findings in 69 cases from Ørebro county 1965 to 1977. Scand J Infect Dis 11: 111–119, 1979
   PubMedGoogle Scholar
• Høst JH, Sander J, Gedde-Dahl TW. Alvorlig meningokokksykdom belyst ved et journalmate-riale. Tidsskr Nor Lægeforen 103: 274–279, 1983
   PubMedGoogle Scholar
• Oakley JR, Stanton AN. Meningococcal infections during infancy: Confidential inquiries into 10 deaths. Br Med J 2: 468–469, 1979
   PubMedGoogle Scholar
• Stiehm ER, Damrosch DS. Factors in the prognosis of meningococcal infections. J Pediatr 68: 457–467, 1966
   PubMed Web of Science ®Google Scholar
• Høyer S. Meningokokk-meningitter i Troms og Finnmark. Tidsskr Nor Lægeforen 90: 1466–1469, 1970
   PubMedGoogle Scholar
• Lewis LS. Prognostic factors in acute meningococcaemia. Arch Dis Childh 54: 44–48, 1979
   PubMed Web of Science ®Google Scholar
• Chalane SF, Waters M. Fulminant meningococcal septicæmia. A hospital experience. Lancet 2: 120–121, 1975
   PubMedGoogle Scholar
• Vik-Mo H, Lote K, Nordøy A. Disseminated intravascular coagulation in patients with meningococcal infection: Laboratory diagnosis and prognostic factors. Scand J Infect Dis 10: 187–191, 1978
   PubMed Web of Science ®Google Scholar
• Bøvre K, Frøholm LO, Gaustad P, Holten E, Høiby EA. Some agent characteristics and their coexistence related to occurrence and severity of systemic meningococcal disease in Norway, winter 1981–1982. NIPH Annals 6: 75–84, 1983
   PubMedGoogle Scholar
• Branham S. The meningococcus (Neisseria intracellularis). Bacteriol Rev 4: 59–96, 1940
   PubMedGoogle Scholar
• Orchard RT, Cramb M. Parkins RA. Chronic meningococcal septicaemia. Practitioner 209: 338–339, 1972
   PubMedGoogle Scholar
• Niklasson P-M, Svanblom M. Prolonged meningococcal septicaemia. A report of four cases and comparison with benign gonococcal septicaemia. Scand J Infect Dis 5: 29–33, 1973
   PubMedGoogle Scholar
• Baltimore RS, Hammerschlag M. Meningococcal bacteremia. Clinical and serologic studies in infants with mild illness. Am J Dis Child 131: 1001–1004, 1977
   PubMedGoogle Scholar
• Olcén P, Eeg-Olofsson, Frydén A, Kernell A, Ånséhn S. Benign meningococcemia in childhood. A report of five cases with clinical and diagnostic remarks. Scand J Infect Dis 10: 107–111. 1978
   PubMed Web of Science ®Google Scholar
• Toews WH, Bass JW. Skin manifestations of meningococcal infection: An immediate indicator of prognosis. Am J Dis Child 127: 173–176, 1971
   Google Scholar
• Conner WT, Minielly JA. Cerebral ædema in fatal meningococcæmia. Lancet 2: 967–968, 1980
   PubMedGoogle Scholar
• Modig J, Hällgren R. Lethal adult respiratory distress syndrome after meningococcal septicemia. Biochemical markers in bronchoalveolar lavage. Resuscitation 13: 159–163. 1986
   PubMedGoogle Scholar
• Robboy SJ. Atrioventricular-node inflammation–mechanism of sudden death in protracted meningococcemia. N Engl J Med 286: 1091–1092, 1972
   PubMedGoogle Scholar
• Hardman JM, Earle KM. Myocarditis in 200 fatal meningococcal infections. Arch Pathol 87: 318–325, 1969
   PubMedGoogle Scholar
• Berthier JC, Hartmann E. L'incompétence myocardique dans le purpura méningococcique de l'enfant. Etude hémodynamique précoce. La Presse Médicale 16: 519–522, 1987
   PubMedGoogle Scholar
• Moss PD. Outcome of meningococcal group B meningitis. Arch Dis Childh 57: 616–621, 1982
   PubMed Web of Science ®Google Scholar
• Jadavji T, Biggar WD, Gold R, Prober CG. Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics 78: 21–25, 1986
   PubMed Web of Science ®Google Scholar
• Sander J, Høst JH, Gedde-Dahl TW, Bay D. Borchgrevink HM, Frøholm LO. Oftedal SI, Vandvik B. Late sequelae after meningococcal disease as related to anamnestic and clinical factors recorded during the acute illness. NIPH Ann 7: 69–75, 1984
   PubMedGoogle Scholar
• Morais de JS, Munford RS, Risi JB, Antezana E, Feldman RA. Epidemic disease due to serogroup C Neisseria meningitidis in Sao Paulo, Brazil. J Infect Dis 129: 568–571, 1974
   PubMedGoogle Scholar
• Wkly Epidem Rec. Meningococcal meningitis 51: 333–337, 1976
   Google Scholar
• Greenwood BM, Cleland PG, Haggie MHK, Lewis LS, Macfarlane JT, Taqi A, Whittle HC. An epidemic of meningococcal infection at Zaria, Northern Nigeria. 2. The changing clinical pattern. Trans R Soc Trop Med Hyg 73: 563–566, 1979
   PubMed Web of Science ®Google Scholar
• Leclerc F, Beuscart R, Guillois B. Diependaele JF, Krim G, Devictor D, Bompard Y, Albada van T. Prognostic factors of severe infectious purpura in children. Intensive Care Med 11: 140–143, 1985
   PubMed Web of Science ®Google Scholar
• Sinclair JF, Skeoch CH, Hallworth D. Prognosis of meningococcal septicaemia. Lancet 2: 38, 1987
   PubMedGoogle Scholar
• Mercier J-C, Beaufils F, Hartmann J-F, Azema D. Hemodynamic patterns of meningococcal shock in children. Crit Care Med 16: 27–33, 1988
   PubMed Web of Science ®Google Scholar
• Cowan BN. The relative prognostic value of lactate and haemodynamic measurements in early schock. Anesthesia 39: 750–755, 1984
   PubMedGoogle Scholar
• Nikado H, Nakae T. The outer membrane of gram-negative bacteria. Adv Microbiol Physiol 20: 163–250, 1979
   PubMedGoogle Scholar
• Mühlradt PF. Topography of outer membrane assembly in Salmonella. J Supramol Struct 5: 103–108, 1976
   PubMedGoogle Scholar
• Rietschel ET, Brade L, Brandenburg K, Flad H-D, Jong-Leuveninck de J, Kawahara K, Lindner B, Loppnow H, Lüderitz T, Schade U, Seydel U, Sidorczyk Z, Tacken A, Zähringer U, Brade H. Chemical structure and biologic activity of bacterial and synthetic lipid A. Rev Infect Dis 9: 527–536, 1987
   Google Scholar
• Leive L, Shovlin VK, Mergenhagen SE. Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. J Biol Chem 243: 6384–6391, 1968
   PubMed Web of Science ®Google Scholar
• Scully MF, Newman YM, Clark SE, Kakkar VV. Evaluation of a chromogenic method for endotoxin measurement. Thromb Res 20: 263–270, 1980
   PubMed Web of Science ®Google Scholar
• Wu LH, Tsai CM, Frasch CE. A method for purification of bacterial R-type lipopolysaccharides. Anal Biochem 160: 281–289, 1987
   PubMedGoogle Scholar
• Jennings HJ, Hawes GB, Adams GA, Kenny CP. The chemical composition and serological reactions of lipopolysaccharides from serogroups A, B, X, and Y Neisseria meningitidis. Can J Biochem 51: 1347–1354, 1973
   PubMedGoogle Scholar
• Jennings HJ, Bhattacharjee AK, Kenne L, Kenny CP, Calver G. The R-type lipopolysaccharides of Neisseria meningitidis. Can J Biochem 58: 128–136, 1980
   PubMedGoogle Scholar
• Hjort PF, Rapaport SI. The Shwartzman reaction: Pathogenetic mechanisms and clinical manifestations. Ann Rev Med 16: 135–168, 1965
   PubMed Web of Science ®Google Scholar
• Galanos C, Freudenberg MA, Lüderitz O, Rietschel ET, Westphal O. Chemical, physiochemical and biological properties of bacterial lipopolysaccharides. In: E. Cohen, eds. Biomedical applications of the horseshoe crab (Limulidae). New York: Alan Liss Inc, 321–332, 1979
   Google Scholar
• Rietschel ET, Wollenweber H-W, Zähringer U, Lüderitz O. Lipid A. the lipid component of bacterial lipopolysaccharides: Relation of chemical structure to biological activity. Klin Wochenschr 60: 705–709, 1982
   PubMedGoogle Scholar
• Jennings HJ, Johnson KG, Kenne L. The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis. Carbohydr Res 121: 233–241, 1983
   PubMed Web of Science ®Google Scholar
• Bryn K, Jantzen E. Analysis of lipopolysaccharides by methanolysis, trifluoroacetylation, and gas chromatography on a fused-silica capillary column. J Chromatogr 240: 405–413, 1982
   Google Scholar
• Hellander IM. Isolation and electrophoretic analysis of bacterial lipopolysaccharides. In: Korhonen TK, Dawes EA, Mäkelä PH, eds. Enterobacterial surface antigens: methods for molecular characterisation. Elsevier Science Publishers, 263–274, 1985
   Google Scholar
• Munford RS, Hall CL, Grimm L. Detection of free endotoxin in cerebrospinal fluid by the Limulus lysate test. Infect Immun 45: 531–533, 1984
   PubMed Web of Science ®Google Scholar
• Obayashi T, Tamura H, Tanaka S, Ohki M, Takahashi S, Kawai T. Endotoxin-inactivating activity in normal and pathological human blood samples. Infect Immun 53: 294–297, 1986
   PubMed Web of Science ®Google Scholar
• Iwanaga S, Morita T, Harada T. Chromogenic substrates for horseshoe crab clotting enzyme, its application for the assay of bacterial endotoxin. Haemostasis 7: 183–188, 1978
   PubMedGoogle Scholar
• Beuss von A, Dolder R, Frauch P, Gebhart T, Greppin R, Hertig K, Widmer J. Studie zum Nachweis von Endotoxinen in Infusionslösungen mit dem Limulustest in Vergleich zum Pyrogentest an Kaninchen. Pharm Acta Helv 51: 167–169, 1976
   PubMedGoogle Scholar
• Noordwijk van J, deJong Y. Comparison of the Limulus test for endotoxin with the rabbit test for pyrogens of the European Pharmacopoeia. J Biol Stand 4: 131–139, 1976
   PubMedGoogle Scholar
• Food and Drug Administration. Draft guideline for validation of the Limulus Amoebocyte lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices. Pharmacopeial Forum: 3012–3020, 1983
   Google Scholar
• Pound NJ. LAL: A Canadian perspective. J Parent Sci Technol 39: 186–189, 1985
   PubMedGoogle Scholar
• Newsome PM. Penicillins and the Limulus Amoebocyte lysate test for endotoxin. J Pharm Pharmacol 29: 704–706, 1977
   PubMedGoogle Scholar
• Baek L, Høiby N, Hertz JB, Espersen F. Interaction between Limulus Amoebocyte lysate and soluble antigens from Pseudomonas aeruginosa and Staphylococcus aureus studied by quantitative immunoelectrophoresis. J Clin Microbiol 22: 229–237, 1985
   PubMedGoogle Scholar
• Brunson KW, Watson DW. Limulus Amoebocyte lysate reaction with streptococcal pyrogenic exotoxin. Infect Immun 14: 1256–1258, 1976
   PubMed Web of Science ®Google Scholar
• Fine DH, Kessler RE, Tabak LA, Shockman GD. Limulus lysate activity of lipotheichoic acids. J Dent Res 56: 1500, 1977
   PubMedGoogle Scholar
• Mikami T, Nagase T, Matsumoto T, Suzuki S, Suzuki M. Gelation of Limulus Amoebocyte lysate by simple polysaccharides. Microbiol Immunol 26: 403–409, 1982
   PubMedGoogle Scholar
• Pearson FC, Bohon J, Lee W, Bruszer G, Sagona M, Dawe R, Jakubowski G, Morrison D, Dinarello C. Comparison of chemical analysis of hollow-fiber dialyzer extracts. Artificial Organs 8: 291–298, 1984
   PubMed Web of Science ®Google Scholar
• McConnell JS, Cohen J. Effect of anticoagulants on the chromogenic Limulus lysate assay for endotoxin. J Clin Pathol 38: 430–432, 1985
   PubMedGoogle Scholar
• Adye JC, Springer GF. Binding of endotoxin (LPS) by glycerophosphatides from human platelets and leukocytes. Naturwissenschaften 64: 150–151, 1977
   PubMedGoogle Scholar
• Baris C, Guest M, Frazer ME. Direct effects of endotoxin on the microcirculation. Advances in Shock Research 4: 153–160, 1980
   PubMedGoogle Scholar
• Schøffel U, Shiga J, Mittermayer C. The proliferation-inhibiting effect of endotoxin on human endothelial cells in culture and its possible implication in states of shock. Circ Shock 9: 499–508, 1982
   PubMedGoogle Scholar
• Haeffner-Cavaillon N, Cavaillon J-M, Szabó L. Cellular receptors for endotoxin. In: Berry LJ, eds. Handbook of endotoxin. Cellular biology of endotoxin. Vol 3. Amsterdam–New York–Oxford: Elsevier, 1–25, 1985
   Google Scholar
• Morrison DC, Vukajlovich SW, Goodman SA, Wollenweber H-W. Regulation of lipopolysaccharide biologic activity by polysaccharide. Bayer-Symposium VIII. The pathogenesis of bacterial infections. Berlin–Heidelberg: Springer-Verlag, 68–84, 1985
   Google Scholar
• Cavaillon J-M, Haeffner-Cavaillon N. The role of serum in interleukin 1 production by human monocytes activated by endotoxins and their polysaccharide moieties. Immunol Letters 10: 35–41, 1985
   PubMedGoogle Scholar
• Dijkstra J, Mellors JW, Ryan JL, Szoka FC. Modulation of the biological activity of bacterial endotoxin by incorporation into lipsomes. J Immunol 138: 2663–2670, 1987
   PubMed Web of Science ®Google Scholar
• Wilson ME. Effects of bacterial endotoxin on neutrophil function. Rev Infect Dis 7: 404–418, 1985
   PubMedGoogle Scholar
• Andersen OK, Volden G, Østerud B, Giercksky K-E. Endotoxin-induced human and porcine leukocyte reactions in vitro. Scand J Clin Lab Invest 46: 143–149, 1986
   PubMed Web of Science ®Google Scholar
• Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Ann Rev Med 38: 417–432, 1987
   PubMed Web of Science ®Google Scholar
• Gaynor E, Bouvier C, Spaet TH. Vascular lesions: Possible pathogenetic basis of the generalized Shwartzman reaction. Science 170: 986–988, 1970
   PubMed Web of Science ®Google Scholar
• Beutler B, Cerami A, Tracey K, Albert J, Lowry S. Cachectin (Tumor necrosis factor): The monokine meditor of shock in sepsis. Abstract. In: Marget W, Lang W, Gabler-Sandberger E, eds. Proceedings of IX International Congress of Infectious and Parasitic Diseases, Munich, July 20–26, volume II: 47–48, 1986
   Google Scholar
• Keppler D, Hagmann W, Rapp S. Role of leukotrienes in endotoxin action in vivo. Rev Infect Dis 9: 580–584, 1987
   Google Scholar
• Dahinden C, Galanos C, Fehr J. Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J Immunol 130: 857–868, 1983
   PubMed Web of Science ®Google Scholar
• Niemetz J, Morrison DC. Lipid A as the biologically active moiety in bacterial endotoxin (LPS)-initiated generation of procoagulant activity by peripheral blood leukocytes. Blood 49: 947–956, 1977
   PubMedGoogle Scholar
• Rickles FR, Rick PD. Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells. J Clin Invest 59: 1188–1195, 1977
   PubMedGoogle Scholar
• Østerud B, Bjørklid E. Human factor VII associated with endotoxin stimulated monocytes in whole blood. Biochem Biophys Res Commun 108: 620–626, 1982
   PubMed Web of Science ®Google Scholar
• Østerud B. Meningococcal septicaemia: The use of plasmapheresis or blood exchange and how to detect severe endotoxin induced white cell activation. Scand J Clin Lab Invest 45 ( Suppl 178): 47–51, 1985
   Google Scholar
• Miragliotta G, Fumarola D. In vitro production of tissue-like substance by mononuclear cells stimulated with Neisseria meningitidis LPS. IRCS Med Sci 11: 729–730, 1983
   Google Scholar
• Morrison DC, Cochrane CG. Direct evidence for Hageman factor (Factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med 140: 797–810, 1974
   PubMed Web of Science ®Google Scholar
• Hawiger J, Hawiger A, Timmons S. Endotoxin-sensitive membrane component of human platelets. Nature 256: 125–126, 1975
   PubMed Web of Science ®Google Scholar
• Galanos C, Lüderitz O. The role of the physical state of lipopolysaccharides in the interaction with complement. Eur J Biochem 65: 403–408, 1976
   PubMedGoogle Scholar
• Di Ninno VL, Chenier VK. Activation of complement by Neisseria meningitidis. FEMS Microbiol Letters 12: 55–60, 1981
   Google Scholar
• Beatty DW, Ryder CR, De V. Heese H. Complement abnormalities during an epidemic of group B meningococcal infection in children. Clin Exp Immunol 64: 465–470, 1986
   PubMed Web of Science ®Google Scholar
• Ross SC, Rosenthal PJ, Berberich HM, Densen P. Killing of Neisseria meningitidis by human neutrophils: Implications for normal and complement-deficient individuals. J Infect Dis 155: 1266–1275, 1987
   Google Scholar
• Jarvis GA, Vedros NA. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect Immun 55: 174–180, 1987
   PubMed Web of Science ®Google Scholar
• Davis CE, Arnold K. Role of meningococcal endotoxin in meningococcal purpura. J Exp Med 140: 159–171, 1974
   PubMed Web of Science ®Google Scholar
• Freudenberg MA, Bøg-Hansen TC, Back U, Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun 28: 373–380, 1980
   PubMedGoogle Scholar
• Wiernik A, Carlson LA, Jarstad C. High-density lipoproteins inhibit the bacterial lipopolysaccharide mediated increase in oxidative metabolism and lysozyme release by neutrophilic granulocytes in vitro. J Clin Lab Immunol 21: 131–135, 1986
   PubMedGoogle Scholar
• Täuber MG, Shibl AM, Hackbarth CJ, Larrick JW, Sande MA. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 156: 456–462, 1987
   PubMed Web of Science ®Google Scholar
• Gathriam P, Gaffin SL, Wells MT, Broch-Utne JG. Superior mesenteric artery occlusion shock in cats: Modification of the endotoxemia by antilipopolysaccharide antibodies (Anti-LPS). Circulatory Shock 19: 231–237, 1986
   PubMedGoogle Scholar
• Davis CE, Ziegler EJ, Arnold KF. Neutralization of meningococcal endotoxin by antibody to core glycolipid. J Exp Med 146: 1007–1017, 1978
   Google Scholar
• Corrigan JJ, Kiernat JF. Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicaemia model. Pediatr Res 13: 48–51, 1979
   PubMedGoogle Scholar
• Emødy L, Ralovich B, Barna K, Brasch G, Ternak G. Physiological effect of orally administered endotoxin to man. J Hyg Epidemiol Microbiol Immunol 18: 454–458, 1974
   PubMedGoogle Scholar
• Greisman SE, Hornick RB. Mechanisms of endotoxin tolerance with special reference to man. J Infect Dis 128: 265–274, 1973
   PubMedGoogle Scholar
• Revhaug A, Michie HR, Manson JM, Watters JM, Dinarello CA, Wolff SM, Wilmore DW. Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans. Arch Surg 123: 162–170, 1988
   PubMedGoogle Scholar
• Elin RJ, Wolff SM, McAdam Kpwj, Chedid L, Audibert F, Oberling F. Properties of reference Escherichia coli endotoxin and its phtalyated derivative in humans. J Infect Dis 144: 329–336, 1981
   PubMed Web of Science ®Google Scholar
• Fink PC, Grunert JH, Endotoxemia in intensive care patients: A longitudinal study with the Limulus Amoebocyte lysate test. Klin Wochenschr 62: 986–991, 1984
   PubMedGoogle Scholar
• Thomas LL, Sturk A, Büller HR, ten Cate JW, Spijker RE, ten Cate H. Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. AJCP 82: 203–206, 1984
   Google Scholar
• Schreibman B, Goldberg P, Kozinn P, Catinella FP, Cunningham JN. Limulus lysate index: Early predictor of fatal sepsis. Curr Surg 42: 119–121, 1985
   PubMedGoogle Scholar
• Pearson FC, Dubczak J, Weary M, Bruszer G, Donohue G. Detection of endotoxin in the plasma of patients with Gram-negative bacterial sepsis by the Limulus Amoebocyte lysate assay. J Clin Microbiol 21: 865–868, 1985
   PubMed Web of Science ®Google Scholar
• Cooperstock M, Riegle L. Plasma Limulus gelation assay in infants and children: Correlation with gram negative bacterial infection and evidence for “intestinal endotoxemia”. In: Bacterial endotoxins: structure, biomedical significance, and detection with the Limulus Amoebocyte lysate test. Alan Liss, Inc, 329–345, 1985
   Google Scholar
• Robinson JA, Klodnycky ML, Loeb HS, Racic R, Gunnar RM. Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man. JAMA 59: 61–67, 1975
   PubMed Web of Science ®Google Scholar
• Harthug S, Bjorvatn B, Østerud B. Quantitation of endotoxin in blood from patients with meningococcal disease using Limulus lysate test in combination with chromogenic substrate. Infection 11: 192–195, 1983
   PubMedGoogle Scholar
• Brandtzæg P, Kierulf P, Engebretsen LF. Plasma LPS and the clinical picture in systemic meningococcal disease. Abstract. Fifth International Pathogenic Neisseria Conference, Noord-wijkenhout, the Netherlands, 14–18 Sept, 1986
   Google Scholar
• Engebretsen LF, Kierulf P, Brandtzæg P. Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease. Thromb Res 42: 713–716, 1986
   PubMedGoogle Scholar
• Egbring R, Seitz R, Blanke H, Leititis J, Kesper J, Burghard R, Fuchs G, Lerch L. The proteinase inhibitor complexes (Antithrombin III-thrombin, alpha 2 antiplasmin-plasmin and alpha 1 antitrypsin-elastase) in septicemia, fulminant hepatic failure and caridac shock: Value for diagnosis and therapy control in CIC/F syndrome. Behring Inst Mitt 79: 87–103, 1986
   Google Scholar
• Blum D, Fondue P, Denolin-Ruebens R, Dubois J. Early heparin therapy in 60 children with acute meningococcemia. Relationship between clinical manifestations and coagulation abnormalities. Acta Chir Belg 72: 288–297, 1973
   PubMedGoogle Scholar
• Miyata T, Torisu M. Plasma endotoxin levels and functions of peripheral granulocytes in surgical patients with respiratory distress syndrome. Jap J Surg 16: 412–417, 1986
   PubMedGoogle Scholar
• Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 133: 913–927, 1986
   PubMed Web of Science ®Google Scholar
• Morgan JF, Morton HJ, Parker RC. Nutrition of animal cells in tissue culture. I. Initial studies of synthetic medium (17557). Proc Soc Exp Biol 73: 1–8, 1950
   PubMed Web of Science ®Google Scholar
• Frauch P. Slide test as a micromethod of a modified Limulus endotoxin test. J Pharm Sci 63. 808–809, 1974
   PubMedGoogle Scholar
• Frasch CE, Chapman SS. Classification of Neisseria meningitidis group B into distinct serotypes. II. Extraction of type-specific antigens for serotyping by precipitin techniques. Infect Immun 6: 127–133, 1972
   PubMed Web of Science ®Google Scholar
• Andersen BM, Solberg O, Frøholm LO. The relationship between endotoxin liberation and serotypes of 25 serogroup B meningococcal strains isolated from patients and carriers. Antonie van Leeuwenhoek 52: 247–248, 1986
   Google Scholar
• Ferry NS, Norton JF, Steele AH. Studies of the properties of boullion filtrates of the meningococcus: Production of a soluble toxin. J Immunol 21: 293–312, 1931
   Google Scholar
• Bishop DG, Work E. An extracellular glycolipid produced by Escherichia coli grown under lysin-limiting conditions. Biochem J 96: 567–576, 1965
   PubMed Web of Science ®Google Scholar
• Crutchley MJ, Marsh DG, Cameron J. Free endotoxin. Nature 214: 1052, 1967
   PubMedGoogle Scholar
• Chatterjee SN, Das J. Electron microscope observations on the excretion of cell-wall material by Vibrio cholerae. J Gen Microbiol 49: 1–11, 1967
   PubMedGoogle Scholar
• Lindsay SS, Wheeler B, Sanderson KE, Costerton JW, Cheng K-J. The release of alkaline phosphatase and of lipopolysaccharide during growth of rough and smooth strains of Salmonella typhimurium. Can J Microbiol 19: 335–343, 1973
   PubMedGoogle Scholar
• DeVoe IW, Gilchrist JE. Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med 138: 1156–167, 1973
   PubMed Web of Science ®Google Scholar
• Jorgensen JH, Smith RF. Measurement of bound and free endotoxin by the Limulus assay (38240). Proc Soc Exp Biol Med 146: 1024–1031, 1974
   PubMed Web of Science ®Google Scholar
• Johnson KG, Pery MB, McDonald IJ, Russell RRB. Cellular and free lipopolysaccharides of some species of Neisseria. Can J Microbiol 21: 1969–1979, 1975
   PubMedGoogle Scholar
• Russell RRB. Free endotoxin—a review. Microbios Letters 2: 125–135, 1976
   Google Scholar
• Kowalewska D, Romanowska E. Comparative studies on the immunologic properties of free endotoxin and lipopolysaccharide from Shigella sonnei. Arch Immunol Therap Exp 25: 323–330, 1977
   PubMedGoogle Scholar
• Munford RS, Hall CL, Lipton JM, Dietschy JM. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J Clin Invest 70: 877–888, 1982
   PubMed Web of Science ®Google Scholar
• Cadieux JE, Kuzio J, Milazzo FH, Kropinski AM. Spontaneous release of lipopolysaccharide by Pseudomonas aeruginosa. J Bacteriol 155: 817–825, 1983
   PubMed Web of Science ®Google Scholar
• Beuvery EC. Miedema F, van Delft RW, Haverkamp J, Leussink AB, te Pas BJ, Teppema KS, Tiesjema RH. Preparation and physiochemical and immunological characterization of polysaccharide-outer membrane protein complexes of Neisseria meningitidis. Infect Immun 40: 369–380, 1983
   PubMedGoogle Scholar
• Tuyau JE, Sims W. Aspects of the pathogenicity of some oral and other haemophili. J Med Microbiol 16: 467–475, 1983
   PubMedGoogle Scholar
• Straus DC, Atkisson DL, Garner CW. Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae. Infect Immun 50: 787–795, 1985
   PubMedGoogle Scholar
• Bartková G, Majtán V, Čizcar;nár I. Properties of free and bound Citrobacter freundii lipopolysaccharides. J Hyg Epidemiol Microbiol Immunol 30: 455–463, 1986
   PubMedGoogle Scholar
• Demonty J, De Graeve J. Release of endotoxic lipopolysaccaride by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum. Med Microbiol Immunol 170: 265–277, 1982
   PubMedGoogle Scholar
• Andersen BM, Solberg O. The endotoxin-liberating effect of antibiotics on meningococci in vitro. Acta Pathol Microbiol Scand (B) 88: 231–236, 1980
   PubMedGoogle Scholar
• Goto H, Nakamura S. Liberation of endotoxin from Escherichia coli by addition of antibiotics. Japan J Exp Med 50: 35–43, 1980
   PubMedGoogle Scholar
• Johnston CA, Greisman SE. Endotoxemia induced by antibiotic therapy: A mechanism for adrenal corticosteroid protection in Gram-negative sepsis. Transact Am Physicians 97: 172–181, 1984
   PubMedGoogle Scholar
• Shenep JL, Mogan KA. Kinetics of endotoxin release during antibiotic therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 150: 380–388, 1984
   PubMed Web of Science ®Google Scholar
• Shenep JL, Barton RP, Mogan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 151: 1012–1018, 1985
   PubMed Web of Science ®Google Scholar
• Walterspiel JW, Kaplan SL, Mason EO. Protective effect of subinhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type b infection in the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment. Pediatr Res 20: 237–241, 1986
   PubMed Web of Science ®Google Scholar
• Cohen J, McConnell JS. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur J Clin Microbiol 5: 13–17, 1986
   PubMedGoogle Scholar
• Zollinger WD, Kasper DL, Veltri BJ, Artenstein MS. Isolation and characterization of a native cell wall complex from Neisseria meningitidis. Infect Immun 6: 835–851, 1972
   PubMedGoogle Scholar
• Gracheva AM, Konovalova OV, Semina NA, Larina LL. Biological and immunological properties of a complex of soluble N. meningitidis antigens of serological groups A, B, and C. ZH Microbiol Epidemiol Immunobiol 6: 33–37, 1976
   Google Scholar
• Vincent H, Bellot. Nouvelles recherches sur le précipito-diagnostic de la méningite cérébro-spinale. Bull Mem Soc Med Hop Paris 27: 952–961, 1909
   Google Scholar
• Rake G. Studies on meningococcus infection. V. The presence of meningococcus precipitogens in the cerebrospinal fluid. J Exp Med 58: 375–383, 1933
   PubMedGoogle Scholar
• Alexander HE. Prognostic value of the precipitin test in meningococcus meningitis. J Clin Invest 16: 207–211, 1937
   PubMedGoogle Scholar
• Edwards EA. Immunological investigations of meningococcal disease. II. Some characteristics of group C antigen of Neisseria meningitidis in the sera of patients with fulminant meningococcemia. J Infect Dis 129: 538–543, 1974
   PubMed Web of Science ®Google Scholar
• Hoffman TA, Edwards EA. Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis. J Infect Dis 126: 636–644, 1972
   PubMed Web of Science ®Google Scholar
• Whittle HC, Greenwood BM, Davidson NMcD, Tomkins A, Tugwell P, Warrell DA, Zalin A, Bryceson ADM, Parry EHO, Brueton M, Duggan M, Oomen JMV, Raykovic AD. Meningococcal antigen in diagnosis and treatment of group A meningococcal infection. Am J Med 58: 823–828, 1975
   PubMed Web of Science ®Google Scholar
• Andersen BM, Skjørten F, Solberg O. Loss of endotoxin liberation in Neisseria meningitidis. An electron microscope study. Acta Pathol Microbiol Scand (B) 89: 271–281, 1981
   PubMedGoogle Scholar
• Solberg O, Andersen BM. Loss of sulfonamide resistance in Neisseria meningitidis. Acta Pathol Microbiol Scand (B) 89: 267–270, 1981
   PubMedGoogle Scholar
• Andersen BM, Solberg O. Release of endotoxin from Neisseria meningitidis. A short survey with a preliminary report on virulence in mice. NIPH Ann 3: 49–55, 1980
   PubMedGoogle Scholar
• Andersen BM, Skjørten F, Solberg O. Effect of penicillin on the morphology of a Neisseria meningitidis strain not liberating free endotoxin. An electron microscope study. Acta Pathol Microbiol Immunol Scand (B) 90: 173–180, 1982
   Google Scholar
• Andersen BM, Solberg O. Effect of benzylpenicillin in mice infected with endotoxin-liberating or non-liberating variant strains of Neisseria meningitidis. Scand J Infect Dis 16: 257–266, 1984
   PubMed Web of Science ®Google Scholar
• Cesarini JP, Vanderkove M, Faucon R, Nicoli J. Ultrastructure de la paroi de Neisseria meningitidis. Ann l'Institut Pasteur 113: 831–841, 1967
   Google Scholar
• Frøholm LO, Jyssum K, Bøvre K. Electron microscopical and cultural features of Neisseria meningitidis competence variants. Acta Pathol Microbiol Scand (B) 81: 525–537, 1973
   Google Scholar
• Andersen BM, Skjørten F, Solberg O. Effect of penicillin on the morphology of a Neisseria meningitidis strain liberating free endotoxin. An electron microscope study. Acta Pathol Microbiol Scand (B) 89: 347–356, 1981
   PubMedGoogle Scholar
• Stephens DS, Edwards KM, Morris F, McGee ZA. Pili and outer membrane appendages on Neisseria meningitidis in the cerebrospinal fluid of an infant. J Infect Dis 146: 568, 1982
   PubMed Web of Science ®Google Scholar
• Wildfeuer A, Heymer B, Schleifer KH, Haferkamp O. Investigations on the specificity of the Limulus test for the detection of endotoxin. Appl Microbiol 28: 867–871, 1974
   PubMedGoogle Scholar
• Verhoef J, Kalter E. Endotoxin effects of peptidoglycan. In: ten Cate JW, Buller HR, Sturk A, Levin J, eds. Progress in clinical and biological research. New York: Alan Liss Inc., 189: 101–113, 1985
   Google Scholar
• Woods JP, Black JR, Barritt DS, Connell TD, Cannon JG. Resistance to meningococcemia apparently conferred by anti-H.8 monoclonal antibody is due to contaminating endotoxin and not to specific immunoprotection. Infect Immun 55: 1927–1928, 1987
   PubMedGoogle Scholar
• Berman NS, Siegel SE, Nachum R, Lipsey A, Leedom J. Cerebrospinal fluid endotoxin concentrations in gram-negative bacterial meningitis. J Pediatr 88: 553–556, 1976
   PubMed Web of Science ®Google Scholar
• Andersen BM, Solberg O. Endotoxin liberation and invasivity of Neisseria meningitidis. Med Trop 43: 65–68, 1983
   Google Scholar
• Frasch CE, McNelis RM, Gotschlich EC. Strain-specific variation in the protein and lipopolysaccharide composition of the group B meningococcal outer membrane. J Bacteriol 127: 973–981, 1976
   PubMedGoogle Scholar
• Tinsley CR, Heckels JE. Variation in expression of pili and outer membrane protein by Neisseria meningitidis during the course of meningococcal infection. J Gen Microbiol 132: 2483–2490, 1986
   PubMedGoogle Scholar
• Jyssum K. Influence of osmotic pressure on transformable and non-transformable variants of Neisseria meningitidis. 2. Growth and induction of autolysis. Acta Pathol Microbiol Scand (B) 83: 24–28, 1975
   Google Scholar
• Chin WL, Lawson JW. Effect of antibiotics on L-form induction of Neisseria meningitidis. Antimicrob Agents Chemother 9: 1056–1065, 1976
   PubMed Web of Science ®Google Scholar
• Davies M, Stewart-Tull DES, Jackson DM. The binding of lipopolysaccharide from Escherichia coli to mammalian cell membranes and its effect on liposomes. Biochem Biophys Acta 508: 260–276, 1978
   PubMed Web of Science ®Google Scholar
• Hitchcock PJ, Leive L, Mäkelä H, Rietschel ET, Strittmatter W, Morrison DC. Lipopolysaccharide nomenclature–past, present and future. J Bacteriol 166: 699–705, 1986
   PubMed Web of Science ®Google Scholar
• Craven DE, Peppler MS, Frasch CE, Mocca LF, McGrath PP, Washington G. Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis 142: 556–568, 1980
   PubMed Web of Science ®Google Scholar
• Galaid EI, Cherubin CE, Marr JS, Schaefler JS, Barone J, Lee W. Meningococcal disease in New York City, 1973 to 1978. Recognition of groups Y and W-135 as frequent pathogens. JAMA 244: 2167–2171, 1980
   PubMed Web of Science ®Google Scholar
• Ryan NJ, Hogan GR, Bonner MC. Meningococcal meningitis in children: Clinical comparison of disease produced by the minor and major serological groups of Neisseria meningitidis. South Med J 77: 1234–1239, 1984
   PubMed Web of Science ®Google Scholar
• Galazka A. Meningococcal disease and its control with meningococcal polysaccharide vaccines. Bull WHO 60: 1–7, 1982
   PubMed Web of Science ®Google Scholar
• Zwalen A, Winkelstein JA, Moxon ER. Surface determinants of Haemophilus influenzae pathogenicity: Comparative virulence of capsular transformants in normal and complement-depleted rats. J Infect Dis 148: 385–394, 1983
   PubMedGoogle Scholar
• Moxon ER. Antigen expression influencing tissue invasion of Haemophilus influenzae type b. In: Bayer-Symposium VIII. The pathogenesis of bacterial infections. Berlin-Heidelberg, Springer-Verlag, 17–29, 1985
   Google Scholar
• Kimura A, Hansen EJ. Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence. Infect Immun 51: 69–79, 1986
   PubMed Web of Science ®Google Scholar
• Takala AK, Eskola J, Bol P, Alphen van L, Palmgren J, Mäkelä PH. Haemophilus influenzae type b strains of outer membrane subtypes 1 and 1c cause different types of invasive disease. Lancet 2: 647–650, 1987
   PubMedGoogle Scholar
• Farries JS, Dickson W, Greenwood E, Malhotra TR, Abbott JD, Jones DM. Meningococcal infections in Bolton, 1971–74. Lancet 2: 118–120, 1975
   PubMed Web of Science ®Google Scholar
• Holten E. The serogroup and serotype patterns of meningococci in Norway are changing. NIPH Ann 3: 37, 1980
   Google Scholar
• Jones DM, Eldridge J, Sutcliffe EM. Emergence of group B type 15 strains as a cause of meningococcal infection in England and Wales. Antonie van Leeuwenhoek 52: 206–208, 1986
   Google Scholar
• Cartwright KAV, Stuart JM, Noah ND. An outbreak of meningococcal disease in Gloucestershire. Lancet 2: 558–561, 1986
   PubMed Web of Science ®Google Scholar
• Ward KN, Fleer A, Verhoef J, Jones DM. Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: Comparison of sulphonamide sensitive and resistant strains. J Clin Pathol 40: 361–367, 1987
   PubMedGoogle Scholar
• Salit IE, Tomalty L. Experimental meningococcal infection in neonatal mice: Differences in virulence between strains isolated from human cases and carriers. Can J Microbiol 30: 1044–1045, 1984
   Google Scholar
• Gregg R, Melly A, Hellerqvist CG, Coniglio JG, McGee ZA. Toxic activity of purified lipopolysaccharide of Neisseria gonorrhoeae for human fallopian tube mucosa. J Infect Dis 143: 432–439, 1981
   PubMed Web of Science ®Google Scholar
• Cooper MD, McGraw PA, Melly A. Localization of gonococcal lipopolysaccharide and its relationship to toxic damage in human fallopian tube mucosa. Infect Immun 51: 425–430, 1986
   PubMedGoogle Scholar
• Denny FW. Effect of a toxin produced by Haemophilus influenzae on ciliated respiratory epithelium. J Infect Dis 129: 93–100, 1974
   PubMed Web of Science ®Google Scholar
• Parker MT. Pyogenic infections, generalized and local. In: Wilson G, Miles A, Parker MT, eds. Topley and Wilson's Principles of bacteriology, virology, and immunity. 7th ed. vol. 3. Smith, GR, eds. Bacterial diseases. London: E Arnold Ltd, 170–191, 1985
   Google Scholar
• Sullivan TD, LaScola LJ. Neisseria meningitidis bacteriemia in children: Quantitation of bacteremia and spontaneous clinical recovery without antibiotic therapy. Pediatrics 80: 63–67, 1987
   PubMed Web of Science ®Google Scholar
• McCracken GH, Sarff LD. Endotoxin in cerebrospinal fluid. Detection in neonates with bacterial meningitis. JAMA 235: 617–620, 1976
   Web of Science ®Google Scholar
• Feldman WE. Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. N Engl J Med 296: 433–435, 1977
   PubMed Web of Science ®Google Scholar
• DeVoe IW, Gilka F. Disseminated intravascular coagulation in rabbits: Synergistic activity of meningococcal endotoxin and materials egested from leukocytes containing meningococci. J Med Microbiol 9: 451–458, 1976
   PubMedGoogle Scholar
• Movat HZ, Cybulsky MI, Colditz IG, Chan MKW, Dinarello CA. Acute inflammation in gram-negative infection: Endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc 46: 97–104, 1987
   PubMedGoogle Scholar
• Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1: 355–357, 1987
   PubMed Web of Science ®Google Scholar
• Rothstein JL, Schreiber H. Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA 85: 607–611, 1988
   PubMed Web of Science ®Google Scholar
• Formsgaard A, Worsaae H, Bendtzen K. Detection of tumor necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzym-linked immunosorbent assay and cytotoxicity bioassay. Scand J Immunol 27: 143–147, 1988
   PubMedGoogle Scholar